A federal shift to Schedule III could free licensed operators from punishing tax rules and open doors to mainstream banking — with significant implications for Florida's medical cannabis economy
The medical cannabis industry is preparing for what could be the most consequential federal shift in decades, as the reclassification of medical marijuana to a Schedule III substance stands to ease tax burdens, expand access to banking, and reshape the financial outlook for licensed operators across South Florida. For Miami-Dade County, where medical cannabis touches patient care, small business growth, and regional economic development, the change carries far-reaching public interest.
The Marijuana and Medical Marijuana Education and Research Initiative (MMERI) at Florida A&M University recently spotlighted the issue through commentary featuring Dyezae Smith, a Tampa-based certified public accountant and owner of Aezalle Tax Advisor. Her analysis offers a window into how rescheduling could ripple through the state's licensed cannabis sector — and what business owners, patients, and community stakeholders should expect in the months ahead.
A Long-Awaited Shift In Federal Tax Treatment
For years, licensed medical marijuana operators have shouldered effective tax rates as high as 60 percent, a consequence of Section 280E of the federal tax code. That provision bars businesses dealing in Schedule I or Schedule II substances from deducting ordinary operating costs such as rent, payroll, and marketing. The reclassification to Schedule III would lift that restriction beginning with 2026 tax filings, according to Smith.
The financial impact could be substantial. Smith projects that the change may return millions of dollars to licensed cannabis businesses that have absorbed the weight of 280E for years. "Many businesses are going to use that additional capital coming into their businesses to pay off loans and other debts related to business activity," she said.
The shift also lands in a state where medical cannabis has become a meaningful contributor to small business activity and patient access to alternative treatment. Florida's licensed operators, including those serving Miami-Dade patients, have long argued that 280E forced them to operate under conditions no other regulated industry faces. Readers following the evolution of Florida's medical marijuana landscape and the broader business and economy beat will recognize the long road to this moment.
What It Means For South Florida Communities
Beyond tax relief, the rescheduling carries implications that reach directly into community life. Smith notes that while the U.S. Department of Justice has pushed for relief on prior 280E penalties, the Internal Revenue Service has not signaled that amended returns will be permitted. That uncertainty tempers expectations for retroactive refunds, but it does not diminish the forward-looking opportunity.
One of the most consequential possibilities involves banking. Licensed cannabis businesses have historically struggled to secure standard banking services, often operating on a cash basis that creates security risks and limits growth. Smith is optimistic that rescheduling could prompt regional banks and credit unions to extend services to medical cannabis operators — a shift that could improve workplace safety, streamline payroll, and support business expansion in Miami-Dade and across South Florida.
For patients, the downstream effects could mean more stable dispensary operations and potentially more competitive pricing as operating costs ease. For the regional economy, it could mean stronger small business growth and a more transparent financial ecosystem around an industry that has operated at the margins of conventional finance.
MMERI's ongoing public education work continues to play a role in helping Floridians understand these developments. The initiative's "Cannabis Conversations" virtual forum, in which Smith discusses "The Ripple Effects of Cannabis Rescheduling," is available at bit.ly/MMERIMAY2026. For readers tracking how federal policy intersects with local public health and community awareness, MMERI's commentary offers a measured, research-grounded perspective.
The road ahead will depend on how federal agencies finalize implementation and how the financial sector responds. What is clear is that medical cannabis businesses, patients, and the South Florida communities they serve are entering a new chapter — one shaped by tax relief, expanded access, and renewed potential for sustainable growth.
Subscribe to Calle Ocho News for weekly updates on policy, business, and community developments shaping Miami-Dade County. For advertising, sponsorship, and partnership opportunities, contact Pressnet Corp.